Antibodies to MHC class II molecules induce autoimmunity: Critical role for macrophages in the immunopathogenesis of obliterative airway disease

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Takenaka, Masashi ^a   Tiriveedhi, Venkataswarup ^a   Subramanian, Vijay ^a   Hoshinaga, Kiyotaka ^b   Patterson, Alexander G ^a   Mohanakumar, Thalachallour ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; AUTOANTIGEN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 8A; CD206 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; COLLAGEN TYPE 5; CXCL13 CHEMOKINE; FIBROBLAST GROWTH FACTOR 6; GLYCOPROTEIN P 15095; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; NERVE GROWTH FACTOR BETA SUBUNIT; SOMATOMEDIN B; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; LUNG ALVEOLUS EPITHELIUM; LUNG INFILTRATE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OBSTRUCTIVE AIRWAY DISEASE; PHENOTYPE; PROTEIN EXPRESSION; TH17 CELL;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; BRONCHIOLITIS OBLITERANS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHEMOKINES; DISEASE MODELS, ANIMAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOPHENOTYPING; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; TH17 CELLS;

EID: 84865024370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042370     Document Type: Article

References (56)

1. Boehler A, Estenne M, (2003) Post-transplant bronchiolitis obliterans. Eur Respir J 22: 1007-1018.
2. Hachem RR, Trulock EP, (2004) Bronchiolitis obliterans syndrome: pathogenesis and management. Semin Thorac Cardiovasc Surg 16: 350-355.
3. Smith MA, Sundaresan S, Mohanakumar T, Trulock EP, Lynch JP, et al. (1998) Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 116: 812-820.
4. Tiriveedhi V, Weber J, Seetharam A, Mohanakumar T, (2010) Cross-talk of alloimmune response and autoimmunity: role in pathogenesis of chronic rejection. Discov Med 9: 229-235.
5. Hachem RR, (2009) Lung allograft rejection: diagnosis and management. Curr Opin Organ Transplant 14: 477-482.
6. Ashwell JD, Chen C, Schwartz RH, (1986) High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J Immunol 136: 389-395.
7. Benichou G, Fedoseyeva EV, (1996) The contribution of peptides to T cell allorecognition and allograft rejection. Int Rev Immunol 13: 231-243.
8. Sayegh MH, Turka LA, (1998) The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 338: 1813-1821.
9. Zarkhin V, Li L, Sarwal M, (2008) "To B or not to B?" B-cells and graft rejection. Transplantation 85: 1705-1714.
10. Halloran PF, Schlaut J, Solez K, Srinivasa NS, (1992) The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 53: 550-555.
11. Girnita AL, Webber SA, Zeevi A, (2006) Anti-HLA alloantibodies in pediatric solid organ transplantation. Pediatr Transplant 10: 146-153.
12. Sundaresan S, Mohanakumar T, Smith MA, Trulock EP, Lynch J, et al. (1998) HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 65: 648-653.
13. Heeger PS, (2003) T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 3: 525-533.
14. Saadi S, Platt JL, (2002) Humoral rejection and endothelial cell activation, 2001. Xenotransplantation 9: 239-241.
15. Vos IH, Briscoe DM, (2002) Endothelial injury: cause and effect of alloimmune inflammation. Transpl Infect Dis 4: 152-159.
16. Jaramillo A, Smith CR, Maruyama T, Zhang L, Patterson GA, et al. (2003) Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol 64: 521-529.
17. Lu KC, Jaramillo A, Mendeloff EN, Huddleston CB, Sweet SC, et al. (2003) Concomitant allorecognition of mismatched donor HLA class I- and class II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 22: 35-43.
18. Reznik SI, Jaramillo A, SivaSai KS, Womer KL, Sayegh MH, et al. (2001) Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 1: 228-235.
19. Saini D, Weber J, Ramachandran S, Phelan D, Tiriveedhi V, et al. (2011) Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant 30: 624-631.
20. Jaramillo A, Smith MA, Phelan D, Sundaresan S, Trulock E, et al. (1999) Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. Transplant Proc 31: 185-186.
21. Bharat A, Kuo E, Steward N, Aloush A, Hachem R, et al. (2008) Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg 86: 189-195 discussion 196-187.
22. Tiriveedhi V, Angaswamy N, Brand D, Weber J, Gelman AG, et al. (2012) A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection. Clin Exp Immunol 167: 158-168.
23. Seetharam A, Tiriveedhi V, Mohanakumar T, (2010) Alloimmunity and autoimmunity in chronic rejection. Curr Opin Organ Transplant 15: 531-536.
24. Nath DS, Basha HI, Mohanakumar T, (2010) Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection. Curr Opin Organ Transplant 15: 16-20.
25. Fukami N, Ramachandran S, Saini D, Walter M, Chapman W, et al. (2009) Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol 182: 309-318.
26. Bharat A, Fields RC, Steward N, Trulock EP, Patterson GA, et al. (2006) CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant 6: 1799-1808.
27. Bharat A, Fields RC, Trulock EP, Patterson GA, Mohanakumar T, (2006) Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J Immunol 177: 5631-5638.
28. Kreisel D, Richardson SB, Li W, Lin X, Kornfeld CG, et al. (2010) Cutting edge: MHC class II expression by pulmonary nonhematopoietic cells plays a critical role in controlling local inflammatory responses. J Immunol 185: 3809-3813.
29. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR, (2008) Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 57: 3239-3246.
30. Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, et al. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58: 2574-2582.
31. Kreisel D, Gelman AE, Palmer SM, (2011) In pursuit of new experimental models of obliterative bronchiolitis. Am J Transplant 11: 882-883.
32. Hele DJ, Yacoub MH, Belvisi MG, (2001) The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis. Respir Res 2: 169-183.
33. Okazaki M, Krupnick AS, Kornfeld CG, Lai JM, Ritter JH, et al. (2007) A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant 7: 1672-1679.
34. Fan L, Benson HL, Vittal R, Mickler EA, Presson R, et al. (2011) Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. Am J Transplant 11: 911-922.
35. Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, et al. (2007) IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 117: 3498-3506.
36. Ponomarev ED, Maresz K, Tan Y, Dittel BN, (2007) CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27: 10714-10721.
37. Fall N, Barnes M, Thornton S, Luyrink L, Olson J, et al. (2007) Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 56: 3793-3804.
38. Cihakova D, Barin JG, Afanasyeva M, Kimura M, Fairweather D, et al. (2008) Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am J Pathol 172: 1195-1208.
39. Siebert H, Sachse A, Kuziel WA, Maeda N, Bruck W, (2000) The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol 110: 177-185.
40. Ishida Y, Gao JL, Murphy PM, (2008) Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 180: 569-579.
41. Zamilpa R, Kanakia R, Cigarroa Jt, Dai Q, Escobar GP, et al. (2011) CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol 300: H1418-1426.
42. Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B, (2007) Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 8: 1086-1094.
43. Bailey SL, Schreiner B, McMahon EJ, Miller SD, (2007) CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat Immunol 8: 172-180.
44. Haque MA, Mizobuchi T, Yasufuku K, Fujisawa T, Brutkiewicz RR, et al. (2002) Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 169: 1542-1549.
45. Boisgerault F, Liu Y, Anosova N, Ehrlich E, Dana MR, et al. (2001) Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation. J Immunol 167: 1891-1899.
46. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, et al. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 160: 3513-3521.
47. Irmler IM, Gajda M, Brauer R, (2007) Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J Immunol 179: 6228-6236.
48. Tang JL, Subbotin VM, Antonysamy MA, Troutt AB, Rao AS, et al. (2001) Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 72: 348-350.
49. Sonderegger I, Rohn TA, Kurrer MO, Iezzi G, Zou Y, et al. (2006) Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur J Immunol 36: 2849-2856.
50. Hsu HC, Yang P, Wang J, Wu Q, Myers R, et al. (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9: 166-175.
51. Weber J, Tiriveedhi V, Takenaka M, Lu W, Hachem R, et al. (2012) Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-alpha-dependant interleukin-17. J Heart Lung Transplant.
52. Vos R, Vanaudenaerde BM, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, et al. (2011) A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 37: 164-172.
53. Nath DS, Tiriveedhi V, Basha HI, Phelan D, Moazami N, et al. (2011) A role for antibodies to human leukocyte antigens, collagen-V, and K-alpha1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy. Transplantation 91: 1036-1043.
54. Saini D, Angaswamy N, Tiriveedhi V, Fukami N, Ramachandran S, et al. (2010) Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation. J Heart Lung Transplant 29: 1330-1336.
55. LeibundGut-Landmann S, Waldburger JM, Reis e Sousa C, Acha-Orbea H, Reith W, (2004) MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat Immunol 5: 899-908.
56. Zhang X, Goncalves R, Mosser DM, (2008) The isolation and characterization of murine macrophages. Curr Protoc Immunol Chapter 14: Unit 14 11.